107 related articles for article (PubMed ID: 19357605)
21. [Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
Si CW
Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):686-7. PubMed ID: 14636449
[No Abstract] [Full Text] [Related]
22. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Lin J; Lott JP; Amorosa VK; Kovarik CL
J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
[No Abstract] [Full Text] [Related]
23. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Grazi G; Bernardi M; Andreone P
Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
[TBL] [Abstract][Full Text] [Related]
24. Sarcoidosis presenting as tattoo changes in a patient undergoing treatment with interferon-alpha and ribavirin.
Werchniak AE; Cheng SX; Dhar AD; Klaus SN
Clin Exp Dermatol; 2004 Sep; 29(5):547-8. PubMed ID: 15347347
[No Abstract] [Full Text] [Related]
25. Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.
Hoffman RG; Cohen MA; Alfonso CA; Weiss JJ; Jones S; Keller M; Condemarín JR; Chiu NM; Jacobson JM
Psychosomatics; 2003; 44(5):417-20. PubMed ID: 12954918
[No Abstract] [Full Text] [Related]
26. Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
Miura Y; Kami M; Yotsuya R; Toda N; Komatsu T
Am J Hematol; 2008 Sep; 83(9):758-9. PubMed ID: 18615552
[No Abstract] [Full Text] [Related]
27. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
Li Z; Zhang Y; An J; Feng Y; Deng H; Xiao S; Ji F
J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
[TBL] [Abstract][Full Text] [Related]
28. Mania induced by withdrawal of treatment with interferon alfa.
Carpiniello B; Orru MG; Baita A; Pariante CM; Farci G
Arch Gen Psychiatry; 1998 Jan; 55(1):88-9. PubMed ID: 9435767
[No Abstract] [Full Text] [Related]
29. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
Enjoji M; Dainichi T; Gondo H; Urabe K
Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
[TBL] [Abstract][Full Text] [Related]
30. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
[TBL] [Abstract][Full Text] [Related]
31. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
[TBL] [Abstract][Full Text] [Related]
32. Manic induction with interferon alpha therapy.
Goh T; Dhillon R; Bastiampillai T
Aust N Z J Psychiatry; 2011 Nov; 45(11):1004. PubMed ID: 21981775
[No Abstract] [Full Text] [Related]
33. Hepatitis C treatment, HAART and side effects.
TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
[No Abstract] [Full Text] [Related]
34. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
[No Abstract] [Full Text] [Related]
35. Treatment induced leucopenia in hepatitis C and Role of G-CSF in its management.
Shafi MS; Sheikh NI; Rizvi F; Afzal M; Manzoor S
J Coll Physicians Surg Pak; 2009 Jun; 19(6):346-9. PubMed ID: 19486571
[TBL] [Abstract][Full Text] [Related]
36. Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.
Scheler M; Proelss J; Bräuninger W; Bieber T; Wenzel J
Dermatology; 2007; 215(3):236-9. PubMed ID: 17823522
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
38. Side effects of interferon-alpha in treating hepatitis C virus infection.
Fontaine H; Pol S
Transplant Proc; 2001 May; 33(3):2327-9. PubMed ID: 11377548
[No Abstract] [Full Text] [Related]
39. Ribavirin and pegylated interferon treatment for hepatitis C was associated not only with semen alterations but also with sperm deoxyribonucleic acid fragmentation in humans.
Pecou S; Moinard N; Walschaerts M; Pasquier C; Daudin M; Bujan L
Fertil Steril; 2009 Mar; 91(3):933.e17-22. PubMed ID: 18930227
[TBL] [Abstract][Full Text] [Related]
40. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
